Global Induced Pluripotent Stem Cells Service Market Research Report 2026

Induced Pluripotent Stem Cells Service Market

Induced pluripotent stem cell (iPSC) services refer to a series of professional technologies and processes designed to reprogram pluripotent stem cells from adult cells (such as skin or blood cells). These cells can self-renew and differentiate into a variety of cell types, and have a wide range of application potential, including regenerative medicine, drug screening, and disease model construction. iPSC manufacturing services are the core of iPSC services, including the selection of cell sources and the implementation of cell reprogramming. Through precise induction technology, researchers can convert mature somatic cells into iPSCs. iPSC reprogramming services focus on using various methods (such as viral vectors, transfection, or small molecule compounds) to achieve cell reprogramming. These methods can effectively improve the efficiency of reprogramming and the safety of cells. Once iPSCs are generated, iPSC culture services become key. This service ensures that iPSCs grow under optimal conditions, maintain their pluripotency, and avoid differentiation. Next, iPSC differentiation services can be used to induce iPSCs to differentiate into specific cell types, such as neurons, cardiomyocytes, etc., to meet research and treatment needs. In addition, iPSC gene editing services enable researchers to make precise gene modifications in iPSCs, facilitating the study of gene function, disease mechanisms, and the development of personalized treatment plans. In summary, induced pluripotent stem cell services cover multiple aspects such as iPSC manufacturing, reprogramming, culture, differentiation, and gene editing, providing strong support for regenerative medicine and biomedical research.

The North American market for Induced Pluripotent Stem Cells Service is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Induced Pluripotent Stem Cells Service is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Induced Pluripotent Stem Cells Service in Pharmaceutical Company is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Induced Pluripotent Stem Cells Service include Lonza, Thermo Fisher Scientific Inc., FUJIFILM Cellular Dynamics, Inc. (FCDI), Charles River Laboratories, Novo Holdings (Catalent, Inc), Creative Bioarray, Creative Biolabs, iXCells Biotechnologies, Creative Biogene, Axol Bioscience Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Induced Pluripotent Stem Cells Service market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Induced Pluripotent Stem Cells Service. The Induced Pluripotent Stem Cells Service market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Induced Pluripotent Stem Cells Service market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Induced Pluripotent Stem Cells Service manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Induced Pluripotent Stem Cells Service Market Report

Chapter Outline

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Induced Pluripotent Stem Cells Service Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 iPSC Manufacturing Service

1.2.3 iPSC Reprogramming Service

1.2.4 iPSC Culture Service

1.2.5 iPSC Differentiation Service

1.2.6 iPSC Gene Editing Service

1.2.7 Other

1.3 Market by Application

1.3.1 Global Induced Pluripotent Stem Cells Service Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Pharmaceutical Company

1.3.3 Laboratory

1.3.4 Scientific Research Institution

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2.1 Global Induced Pluripotent Stem Cells Service Market Perspective (2021–2032)

2.2 Global Induced Pluripotent Stem Cells Service Growth Trends by Region

2.2.1 Global Induced Pluripotent Stem Cells Service Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Induced Pluripotent Stem Cells Service Historic Market Size by Region (2021–2026)

2.2.3 Induced Pluripotent Stem Cells Service Forecasted Market Size by Region (2027–2032)

2.3 Induced Pluripotent Stem Cells Service Market Dynamics

2.3.1 Induced Pluripotent Stem Cells Service Industry Trends

2.3.2 Induced Pluripotent Stem Cells Service Market Drivers

2.3.3 Induced Pluripotent Stem Cells Service Market Challenges

2.3.4 Induced Pluripotent Stem Cells Service Market Restraints

3.1 Global Top Induced Pluripotent Stem Cells Service Players by Revenue

3.1.1 Global Top Induced Pluripotent Stem Cells Service Players by Revenue (2021–2026)

3.1.2 Global Induced Pluripotent Stem Cells Service Revenue Market Share by Players (2021–2026)

3.2 Global Top Induced Pluripotent Stem Cells Service Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Induced Pluripotent Stem Cells Service Revenue

3.4 Global Induced Pluripotent Stem Cells Service Market Concentration Ratio

3.4.1 Global Induced Pluripotent Stem Cells Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Induced Pluripotent Stem Cells Service Revenue in 2025

3.5 Global Key Players of Induced Pluripotent Stem Cells Service Head Offices and Areas Served

3.6 Global Key Players of Induced Pluripotent Stem Cells Service, Products and Applications

3.7 Global Key Players of Induced Pluripotent Stem Cells Service, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4.1 Global Induced Pluripotent Stem Cells Service Historic Market Size by Type (2021–2026)

4.2 Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Type (2027–2032)

5.1 Global Induced Pluripotent Stem Cells Service Historic Market Size by Application (2021–2026)

5.2 Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Application (2027–2032)

6.1 North America Induced Pluripotent Stem Cells Service Market Size (2021–2032)

6.2 North America Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Induced Pluripotent Stem Cells Service Market Size by Country (2021–2026)

6.4 North America Induced Pluripotent Stem Cells Service Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7.1 Europe Induced Pluripotent Stem Cells Service Market Size (2021–2032)

7.2 Europe Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Induced Pluripotent Stem Cells Service Market Size by Country (2021–2026)

7.4 Europe Induced Pluripotent Stem Cells Service Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8.1 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size (2021–2032)

8.2 Asia-Pacific Induced Pluripotent Stem Cells Service Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2021–2026)

8.4 Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9.1 Latin America Induced Pluripotent Stem Cells Service Market Size (2021–2032)

9.2 Latin America Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2021–2026)

9.4 Latin America Induced Pluripotent Stem Cells Service Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10.1 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size (2021–2032)

10.2 Middle East & Africa Induced Pluripotent Stem Cells Service Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2021–2026)

10.4 Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11.1 Lonza

11.1.1 Lonza Company Details

11.1.2 Lonza Business Overview

11.1.3 Lonza Induced Pluripotent Stem Cells Service Introduction

11.1.4 Lonza Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.1.5 Lonza Recent Development

11.2 Thermo Fisher Scientific Inc.

11.2.1 Thermo Fisher Scientific Inc. Company Details

11.2.2 Thermo Fisher Scientific Inc. Business Overview

11.2.3 Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Introduction

11.2.4 Thermo Fisher Scientific Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.2.5 Thermo Fisher Scientific Inc. Recent Development

11.3 FUJIFILM Cellular Dynamics, Inc. (FCDI)

11.3.1 FUJIFILM Cellular Dynamics, Inc. (FCDI) Company Details

11.3.2 FUJIFILM Cellular Dynamics, Inc. (FCDI) Business Overview

11.3.3 FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Introduction

11.3.4 FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.3.5 FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Development

11.4 Charles River Laboratories

11.4.1 Charles River Laboratories Company Details

11.4.2 Charles River Laboratories Business Overview

11.4.3 Charles River Laboratories Induced Pluripotent Stem Cells Service Introduction

11.4.4 Charles River Laboratories Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.4.5 Charles River Laboratories Recent Development

11.5 Novo Holdings (Catalent, Inc)

11.5.1 Novo Holdings (Catalent, Inc) Company Details

11.5.2 Novo Holdings (Catalent, Inc) Business Overview

11.5.3 Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Introduction

11.5.4 Novo Holdings (Catalent, Inc) Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.5.5 Novo Holdings (Catalent, Inc) Recent Development

11.6 Creative Bioarray

11.6.1 Creative Bioarray Company Details

11.6.2 Creative Bioarray Business Overview

11.6.3 Creative Bioarray Induced Pluripotent Stem Cells Service Introduction

11.6.4 Creative Bioarray Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.6.5 Creative Bioarray Recent Development

11.7 Creative Biolabs

11.7.1 Creative Biolabs Company Details

11.7.2 Creative Biolabs Business Overview

11.7.3 Creative Biolabs Induced Pluripotent Stem Cells Service Introduction

11.7.4 Creative Biolabs Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.7.5 Creative Biolabs Recent Development

11.8 iXCells Biotechnologies

11.8.1 iXCells Biotechnologies Company Details

11.8.2 iXCells Biotechnologies Business Overview

11.8.3 iXCells Biotechnologies Induced Pluripotent Stem Cells Service Introduction

11.8.4 iXCells Biotechnologies Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.8.5 iXCells Biotechnologies Recent Development

11.9 Creative Biogene

11.9.1 Creative Biogene Company Details

11.9.2 Creative Biogene Business Overview

11.9.3 Creative Biogene Induced Pluripotent Stem Cells Service Introduction

11.9.4 Creative Biogene Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.9.5 Creative Biogene Recent Development

11.10 Axol Bioscience Ltd.

11.10.1 Axol Bioscience Ltd. Company Details

11.10.2 Axol Bioscience Ltd. Business Overview

11.10.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Introduction

11.10.4 Axol Bioscience Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.10.5 Axol Bioscience Ltd. Recent Development

11.11 Elixirgen Scientific, Inc.

11.11.1 Elixirgen Scientific, Inc. Company Details

11.11.2 Elixirgen Scientific, Inc. Business Overview

11.11.3 Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Introduction

11.11.4 Elixirgen Scientific, Inc. Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.11.5 Elixirgen Scientific, Inc. Recent Development

11.12 Cyagen

11.12.1 Cyagen Company Details

11.12.2 Cyagen Business Overview

11.12.3 Cyagen Induced Pluripotent Stem Cells Service Introduction

11.12.4 Cyagen Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.12.5 Cyagen Recent Development

11.13 ALSTEM

11.13.1 ALSTEM Company Details

11.13.2 ALSTEM Business Overview

11.13.3 ALSTEM Induced Pluripotent Stem Cells Service Introduction

11.13.4 ALSTEM Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.13.5 ALSTEM Recent Development

11.14 uBriGene Biosciences International Co.

11.14.1 uBriGene Biosciences International Co. Company Details

11.14.2 uBriGene Biosciences International Co. Business Overview

11.14.3 uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Introduction

11.14.4 uBriGene Biosciences International Co. Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.14.5 uBriGene Biosciences International Co. Recent Development

11.15 NEXEL Co., Ltd.

11.15.1 NEXEL Co., Ltd. Company Details

11.15.2 NEXEL Co., Ltd. Business Overview

11.15.3 NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Introduction

11.15.4 NEXEL Co., Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (2021–2026)

11.15.5 NEXEL Co., Ltd. Recent Development

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

List of Tables

 Table 1. Global Induced Pluripotent Stem Cells Service Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

 Table 2. Key Players of iPSC Manufacturing Service

 Table 3. Key Players of iPSC Reprogramming Service

 Table 4. Key Players of iPSC Culture Service

 Table 5. Key Players of iPSC Differentiation Service

 Table 6. Key Players of iPSC Gene Editing Service

 Table 7. Key Players of Other

 Table 8. Global Induced Pluripotent Stem Cells Service Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

 Table 9. Global Induced Pluripotent Stem Cells Service Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 10. Global Induced Pluripotent Stem Cells Service Market Size by Region (US$ Million), 2021–2026

 Table 11. Global Induced Pluripotent Stem Cells Service Market Share by Region (2021–2026)

 Table 12. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Region (US$ Million), 2027–2032

 Table 13. Global Induced Pluripotent Stem Cells Service Market Share by Region (2027–2032)

 Table 14. Induced Pluripotent Stem Cells Service Market Trends

 Table 15. Induced Pluripotent Stem Cells Service Market Drivers

 Table 16. Induced Pluripotent Stem Cells Service Market Challenges

 Table 17. Induced Pluripotent Stem Cells Service Market Restraints

 Table 18. Global Induced Pluripotent Stem Cells Service Revenue by Players (US$ Million), 2021–2026

 Table 19. Global Induced Pluripotent Stem Cells Service Market Share by Players (2021–2026)

 Table 20. Global Top Induced Pluripotent Stem Cells Service Players by Tier (Tier 1, Tier 2, and Tier 3), based on Induced Pluripotent Stem Cells Service Revenue, 2025

 Table 21. Ranking of Global Top Induced Pluripotent Stem Cells Service Companies by Revenue (US$ Million) in 2025

 Table 22. Global 5 Largest Players Market Share by Induced Pluripotent Stem Cells Service Revenue (CR5 and HHI), 2021–2026

 Table 23. Global Key Players of Induced Pluripotent Stem Cells Service, Headquarters and Area Served

 Table 24. Global Key Players of Induced Pluripotent Stem Cells Service, Products and Applications

 Table 25. Global Key Players of Induced Pluripotent Stem Cells Service, Date of General Availability (GA)

 Table 26. Mergers and Acquisitions, Expansion Plans

 Table 27. Global Induced Pluripotent Stem Cells Service Market Size by Type (US$ Million), 2021–2026

 Table 28. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Type (2021–2026)

 Table 29. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Type (US$ Million), 2027–2032

 Table 30. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Type (2027–2032)

 Table 31. Global Induced Pluripotent Stem Cells Service Market Size by Application (US$ Million), 2021–2026

 Table 32. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Application (2021–2026)

 Table 33. Global Induced Pluripotent Stem Cells Service Forecasted Market Size by Application (US$ Million), 2027–2032

 Table 34. Global Induced Pluripotent Stem Cells Service Revenue Market Share by Application (2027–2032)

 Table 35. North America Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 36. North America Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2021–2026

 Table 37. North America Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2027–2032

 Table 38. Europe Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 39. Europe Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2021–2026

 Table 40. Europe Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2027–2032

 Table 41. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 42. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (US$ Million), 2021–2026

 Table 43. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size by Region (US$ Million), 2027–2032

 Table 44. Latin America Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 45. Latin America Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2021–2026

 Table 46. Latin America Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2027–2032

 Table 47. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

 Table 48. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2021–2026

 Table 49. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size by Country (US$ Million), 2027–2032

 Table 50. Lonza Company Details

 Table 51. Lonza Business Overview

 Table 52. Lonza Induced Pluripotent Stem Cells Service Product

 Table 53. Lonza Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 54. Lonza Recent Development

 Table 55. Thermo Fisher Scientific Inc. Company Details

 Table 56. Thermo Fisher Scientific Inc. Business Overview

 Table 57. Thermo Fisher Scientific Inc. Induced Pluripotent Stem Cells Service Product

 Table 58. Thermo Fisher Scientific Inc. Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 59. Thermo Fisher Scientific Inc. Recent Development

 Table 60. FUJIFILM Cellular Dynamics, Inc. (FCDI) Company Details

 Table 61. FUJIFILM Cellular Dynamics, Inc. (FCDI) Business Overview

 Table 62. FUJIFILM Cellular Dynamics, Inc. (FCDI) Induced Pluripotent Stem Cells Service Product

 Table 63. FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 64. FUJIFILM Cellular Dynamics, Inc. (FCDI) Recent Development

 Table 65. Charles River Laboratories Company Details

 Table 66. Charles River Laboratories Business Overview

 Table 67. Charles River Laboratories Induced Pluripotent Stem Cells Service Product

 Table 68. Charles River Laboratories Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 69. Charles River Laboratories Recent Development

 Table 70. Novo Holdings (Catalent, Inc) Company Details

 Table 71. Novo Holdings (Catalent, Inc) Business Overview

 Table 72. Novo Holdings (Catalent, Inc) Induced Pluripotent Stem Cells Service Product

 Table 73. Novo Holdings (Catalent, Inc) Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 74. Novo Holdings (Catalent, Inc) Recent Development

 Table 75. Creative Bioarray Company Details

 Table 76. Creative Bioarray Business Overview

 Table 77. Creative Bioarray Induced Pluripotent Stem Cells Service Product

 Table 78. Creative Bioarray Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 79. Creative Bioarray Recent Development

 Table 80. Creative Biolabs Company Details

 Table 81. Creative Biolabs Business Overview

 Table 82. Creative Biolabs Induced Pluripotent Stem Cells Service Product

 Table 83. Creative Biolabs Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 84. Creative Biolabs Recent Development

 Table 85. iXCells Biotechnologies Company Details

 Table 86. iXCells Biotechnologies Business Overview

 Table 87. iXCells Biotechnologies Induced Pluripotent Stem Cells Service Product

 Table 88. iXCells Biotechnologies Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 89. iXCells Biotechnologies Recent Development

 Table 90. Creative Biogene Company Details

 Table 91. Creative Biogene Business Overview

 Table 92. Creative Biogene Induced Pluripotent Stem Cells Service Product

 Table 93. Creative Biogene Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 94. Creative Biogene Recent Development

 Table 95. Axol Bioscience Ltd. Company Details

 Table 96. Axol Bioscience Ltd. Business Overview

 Table 97. Axol Bioscience Ltd. Induced Pluripotent Stem Cells Service Product

 Table 98. Axol Bioscience Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 99. Axol Bioscience Ltd. Recent Development

 Table 100. Elixirgen Scientific, Inc. Company Details

 Table 101. Elixirgen Scientific, Inc. Business Overview

 Table 102. Elixirgen Scientific, Inc. Induced Pluripotent Stem Cells Service Product

 Table 103. Elixirgen Scientific, Inc. Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 104. Elixirgen Scientific, Inc. Recent Development

 Table 105. Cyagen Company Details

 Table 106. Cyagen Business Overview

 Table 107. Cyagen Induced Pluripotent Stem Cells Service Product

 Table 108. Cyagen Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 109. Cyagen Recent Development

 Table 110. ALSTEM Company Details

 Table 111. ALSTEM Business Overview

 Table 112. ALSTEM Induced Pluripotent Stem Cells Service Product

 Table 113. ALSTEM Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 114. ALSTEM Recent Development

 Table 115. uBriGene Biosciences International Co. Company Details

 Table 116. uBriGene Biosciences International Co. Business Overview

 Table 117. uBriGene Biosciences International Co. Induced Pluripotent Stem Cells Service Product

 Table 118. uBriGene Biosciences International Co. Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 119. uBriGene Biosciences International Co. Recent Development

 Table 120. NEXEL Co., Ltd. Company Details

 Table 121. NEXEL Co., Ltd. Business Overview

 Table 122. NEXEL Co., Ltd. Induced Pluripotent Stem Cells Service Product

 Table 123. NEXEL Co., Ltd. Revenue in Induced Pluripotent Stem Cells Service Business (US$ Million), 2021–2026

 Table 124. NEXEL Co., Ltd. Recent Development

 Table 125. Research Programs/Design for This Report

 Table 126. Key Data Information from Secondary Sources

 Table 127. Key Data Information from Primary Sources

 Table 128. Authors List of This Report

List of Figures

 Figure 1. Induced Pluripotent Stem Cells Service Picture

 Figure 2. Global Induced Pluripotent Stem Cells Service Market Size Comparison by Type (US$ Million), 2021–2032

 Figure 3. Global Induced Pluripotent Stem Cells Service Market Share by Type: 2025 vs 2032

 Figure 4. iPSC Manufacturing Service Features

 Figure 5. iPSC Reprogramming Service Features

 Figure 6. iPSC Culture Service Features

 Figure 7. iPSC Differentiation Service Features

 Figure 8. iPSC Gene Editing Service Features

 Figure 9. Other Features

 Figure 10. Global Induced Pluripotent Stem Cells Service Market Size by Application (US$ Million), 2021–2032

 Figure 11. Global Induced Pluripotent Stem Cells Service Market Share by Application: 2025 vs 2032

 Figure 12. Pharmaceutical Company Case Studies

 Figure 13. Laboratory Case Studies

 Figure 14. Scientific Research Institution Case Studies

 Figure 15. Induced Pluripotent Stem Cells Service Report Years Considered

 Figure 16. Global Induced Pluripotent Stem Cells Service Market Size (US$ Million), Year-over-Year: 2021–2032

 Figure 17. Global Induced Pluripotent Stem Cells Service Market Size, (US$ Million), 2021 vs 2025 vs 2032

 Figure 18. Global Induced Pluripotent Stem Cells Service Market Share by Region: 2025 vs 2032

 Figure 19. Global Induced Pluripotent Stem Cells Service Market Share by Players in 2025

 Figure 20. Global Induced Pluripotent Stem Cells Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

 Figure 21. The Top 10 and 5 Players Market Share by Induced Pluripotent Stem Cells Service Revenue in 2025

 Figure 22. North America Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 23. North America Induced Pluripotent Stem Cells Service Market Share by Country (2021–2032)

 Figure 24. United States Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 25. Canada Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 26. Europe Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 27. Europe Induced Pluripotent Stem Cells Service Market Share by Country (2021–2032)

 Figure 28. Germany Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 29. France Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 30. U.K. Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 31. Italy Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 32. Russia Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 33. Ireland Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 34. Asia-Pacific Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 35. Asia-Pacific Induced Pluripotent Stem Cells Service Market Share by Region (2021–2032)

 Figure 36. China Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 37. Japan Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 38. South Korea Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 39. Southeast Asia Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 40. India Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 41. Australia & New Zealand Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 42. Latin America Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 43. Latin America Induced Pluripotent Stem Cells Service Market Share by Country (2021–2032)

 Figure 44. Mexico Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 45. Brazil Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 46. Middle East & Africa Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 47. Middle East & Africa Induced Pluripotent Stem Cells Service Market Share by Country (2021–2032)

 Figure 48. Israel Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 49. Saudi Arabia Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 50. UAE Induced Pluripotent Stem Cells Service Market Size YoY Growth (US$ Million), 2021–2032

 Figure 51. Lonza Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 52. Thermo Fisher Scientific Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 53. FUJIFILM Cellular Dynamics, Inc. (FCDI) Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 54. Charles River Laboratories Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 55. Novo Holdings (Catalent, Inc) Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 56. Creative Bioarray Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 57. Creative Biolabs Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 58. iXCells Biotechnologies Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 59. Creative Biogene Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 60. Axol Bioscience Ltd. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 61. Elixirgen Scientific, Inc. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 62. Cyagen Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 63. ALSTEM Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 64. uBriGene Biosciences International Co. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 65. NEXEL Co., Ltd. Revenue Growth Rate in Induced Pluripotent Stem Cells Service Business (2021–2026)

 Figure 66. Bottom-up and Top-down Approaches for This Report

 Figure 67. Data Triangulation

 Figure 68. Key Executives Interviewed